New combination therapy for pancreatic carcinomas and colon cancer
The current invention is based on combination therapies of nucleoside analogs with inhibitors of either the Nodal/Activin pathway or the mTOR / hedgehog pathway and show a remarkable capacity to eliminate cancer stem cells
and to subsequently inhibit pancreatic and/or colon cancer.
Further Information: PDF
Bayerische Patentallianz GmbH
Phone: +49 89 5480177-0
Contact
Peer Biskup
Media Contact
Alle Nachrichten aus der Kategorie: Technology Offerings
Neueste Beiträge
Fermented wool is the answer
FAU researchers reveal the secret of the famous Pazyryk carpet Why are the red, yellow, and blue colours used in the world’s oldest knotted-pile carpet still so vivid and bright,…
Advance in ‘optical tweezers’ to boost biomedical research
Much like the Jedis in Star Wars use ‘the force’ to control objects from a distance, scientists can use light or ‘optical force’ to move very small particles. The inventors…
New form of symbiosis discovered
They are also called power plants of the cells: the mitochondria. They are present in almost all eukaryotic cells and they supply the cells with energy. Until now, it was…
